• Distributor
• Contact Us
• Careers
• Events

Get a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.

• One-Stop CAR-T Therapy Development
  • Biomarker Identification & Selection
  • scFv Generation
  • CAR Design & Construction
    • TriCAR Construction Technology
    • Compound CAR (cCAR) Construction Service
    • Exhaustion Resistant CAR-T Cell (c-Jun Overexpression)
    • IL-8R-modified CAR Construction Service
    • Modular CAR (modCAR) Construction Service
    • CAR-T Engineering Service Targeting TRBCs for T-cell Malignancies Immunotherapy
    • pan-ErbB-targeted Combination CAR-T Cell Engineering Service
    • NKG2D-based Universal CAR Engineering Service Using TIM Molecule
    • CAR-T Engineering Strategies for In Vivo Imaging Detection Service
  • CAR-T Gene Packaging & Delivery
    • Electric Transfection
    • Virus Based Transfection
    • Transposons Transfection
  • Replication-Competent Virus Testing Service
  • CAR Cell In Vitro Assay Service
    • Anti-CAR Cell Exhaustion Engineering Service
  • CAR-T Preclinical In Vivo Assay
    • Construction of Xenograft Animal Models
    • Strategies to Harness Cytokine Release Syndrome
    • Efficacy Test of CAR-T
    • Viability and Bio-distribution Study of CAR-T
    • Toxicity Evaluation of CAR-T
    • Quality Control for In Vivo Assays
  • IND Development for CAR-T Cell Therapy
  • GMP Production for CAR-T Products
  • CAR Clinical Trials
• One-Stop TCR-T Therapy Development
  • TCR Biomarker Identification & Selection
    • T Cell Signature Profile Detection Service to Study T-Cell Infiltration of Human Cancers
    • TCR Discovery Platform for Immunotherapy
  • TCR Generation & Optimization
    • TCR Generated from Patient's TIL
    • TCR Generated from Phage Display
    • TCR Generated from In Vivo System
    • TCR Affinity Optimization
  • TCR Design & Construction
  • TCR Gene Packaging & Delivery
    • Retrovirus-mediated TCR Gene Transfer
    • Lentivirus-mediated TCR Gene Transfer
    • Electroporation
  • TCR In Vitro Assay
    • TCR Validation Assay
      • Transgene Expression Assay
      • Lymphocyte Culture and Proliferation Assay
      • Cytokines Release Assay
      • TCR/CD3 Stability Assay
      • TCR Pairing
      • Lymphocyte Antigen Reactivity and Cytotoxicity Assay
    • T Cell Activation Assay
    • TCR Specificity Assay
    • Cytokine Release Assay
    • In Vitro Cytotoxicity Assay
  • TCR-T Preclinical In Vivo Assay
    • Animal Experiments
    • T Cell Trafficking Test
    • T Cell Persistence Test
    • Efficacy Test
    • Safety/Toxicity Evaluation
  • TCR Analysis
    • TCR Repertoire Sequencing
    • TCR Vβ Repertoire Analysis
    • MHC-peptide Tetramer
    • TCR Clonality Assessment
    • TCR Clonality Quantitation and CDR3 Size Diversity Technology
  • TCR Clinical Applications
    • TCR Clinical Diagnostics
    • TCR Clinical Therapeutics
      • TCR Against Cancer
      • TCR Against Autoimmune Disease
      • TCR Against Immunodeficiency
• One-Stop CAR-MA Therapy Development
• One-Stop CAR-NK Therapy Development
  • One-stop CAR-NKT Therapy Development
  • One-stop UniCAR-NK Therapy Development
  • iPSC-derived CAR-NK Therapy Development
  • One-stop TCR-NK Therapy Development
  • NK Cell Genetic Engineering Service
  • NK Cell Expansion Service
• One-stop Cytokine Release Syndrome (CRS) Management Solutions
• One-Stop CAR-B Therapy Development
• TCR-Like Antibody Development Service
  • MHC/Peptide Complex Production for TCR-Like Antibody Discovery
  • TCR-Like Antibody Discovery Strategies
  • TCR-Like Antibody Affinity Characterization
  • TCR-Like CAR Construction and Evaluation Service
• γδ T Cells Engineering Services
• One-Stop Canine CAR-T Therapy Development Services
  • Canine CAR-T Engineering Service
  • Canine CAR-T Development Service for Hematologic Malignancies
  • Canine CAR-T Development Service for Solid Tumor
  • Canine CAR-T Cell Characterization Service
• CellRapeutics™ In Vivo Cell Engineering Development Services
  • In Vivo CAR-T Cell Engineering
    • In Vivo Non-viral CAR-T Cell Engineering
      • In Vivo IVT mRNA-based CAR-T Cell Engineering
      • In Vivo Circular RNA-based CAR-T Cell Engineering
    • In Vivo Viral-based CAR-T Cell Engineering
  • In Vivo B Cell Engineering
  • In Vivo CAR-NK Cell Engineering
  • In Vivo CAR-M Cell Engineering
• scFv-TCR T Cell Therapy Development Service
• One-Stop Silence™ CAR-T Cell Therapy Development Services
• One-Stop mRNA CAR-T Therapy Development
• Vaccine Boosting CAR-T Cell Therapy Solutions Against Solid Tumors
  • Peptide-DC Vaccine Boosting pMHC-directed CAR-T Cell Solutions
  • Amphiphile-ligand Vaccine Boosting CAR-T Cell Solutions
  • RNA Vaccine Boosting CAR-T Cell Solutions
  • Virus-based Vaccine Boosting CAR-T Cell Solutions
• CellRapeutics™ STAb-T Cell Therapy Development
• CellRapeutics™ CART Therapy Development Services in the Non-Cancer Field
  • CellRapeutics™ CART Development Service for Autoimmune Diseases
  • CellRapeutics™ CART Development Service Powering Anti-Aging Field
  • CellRapeutics™ CART Development Service for Fibrotic Diseases
  • CellRapeutics™ CART Development Service Targeting Infectious Diseases
• One-Stop Allogeneic Cell Therapy Development Services
  • Allogeneic CAR-T Therapy Development Services
  • Allogeneic TCR-T Therapy Development Services
  • Allogeneic CAR-NK Therapy Development Services
  • Allogeneic CAR/TCR Cell Design and Engineering Services
  • Other Allogeneic Cell Therapy Development Services
• CellRapeutics™ Anti-HIV CAR Cell Therapy Development
  • HIV CAR Design and Construction
  • HIV CAR Cell Design and Engineering
• CellRapeutics™ Antibody-TCR (AbTCR) Technology
• Organoid-induced Differentiation of Conventional T Cells from hPSCs
• Modular CAR-T Cell Generation with AAV-Cpf1
• High-throughput Screening for T Cell Activity Modulator Discovery
• Nanoparticle Tiny Tech for Programming T Cells
• TRAC-CAR-T Cell Development with CRISPR/Cas9 Technology
  • NR4A Knock Out CAR-T Cell Development with CRISPR Technology
• Virus Specific T Cell (VST) Technology
• Antibody-Coupled T Cell Receptor (ACTR) Platform
• CellRapeutics™ TCR/CAR/Antigen-Engineered Regulatory T Cells (Tregs)
  • CellRapeutics™ CAR-Treg Development
• CellRapeutics™ Chimeric Engulfment Receptor (CER) Technology
• Dendritic Vaccine Development
  • Induction of Antitumor Cytotoxic Lymphocytes Using Engineered Human Primary Blood Dendritic Cells
• Bispecific TCR Development
• Cancer Vaccine Development
  • Cancer Vaccine Discovery
    • Cancer Vaccine Types and Design
    • Tumor Antigen Identification for Cancer Vaccine
    • Adjuvant Candidate Discovery for Cancer Vaccine
    • Biomarker Discovery and Verification for Cancer Vaccine
  • Cancer Vaccine Engineering
    • Gene Synthesis for Cancer Vaccine
    • Peptide Synthesis for Cancer Vaccine
    • Cancer Vaccine Expression Systems
    • GLP-Compliant Cancer Vaccine Production
    • Cancer Vaccine Adjuvant Evaluation
    • Delivery System Development for Cancer Vaccine
    • Development of Serum-Free Culture System
  • Cancer Vaccine Analytical Characterization
    • Cancer Vaccine Identity Testing
    • Cancer Vaccine Purity Testing
    • Cancer Vaccine Microbial Testing
    • Cancer Vaccine Quantity and Stability Testing
  • Cancer Vaccine In Vivo Assessment
    • Preclinical Pharmacology for Cancer Vaccine
  • Cancer Vaccine GMP Manufacturing
• One-Stop CAR-Monocyte Therapy Development
• Other Services
  • HLA Typing Service
  • KIR Typing Service
  • HLA Testing
  • Tumor-infiltrating Lymphocytes-based Antibody Discovery Service
  • Dog DLA Genotyping Service
  • Guinea Pig GPLA Genotyping Service
  • Mouse H2 Genotyping Service
  • Rabbit RLA Genotyping Service
  • Rat RT1 Genotyping Service
  • Rhesus Macaque MHC Genotyping Service

Creative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.

• TCR-T Development Solutions
• CAR-T Development Solutions

• By Diseases
  • Leukemia
  • Lymphoma
  • Carcinoma
  • Sarcoma
  • Blastoma
  • Glioma
  • Germ Cell Tumor
  • Viral Infection
  • Autoimmune Diseases
  • Others
• By Product Types
  • CAR Vectors
  • CAR IVT
  • CAR Viral Particles
  • CAR Cells
  • CAR Kits
  • CAR Complementary
  • TCR Vectors
  • TCR Cells
  • TCR Viral Particles
  • pMHC Microarrays
  • TCR Kits
  • TCR IVT
  • Immune Cells
  • Immune Cell Kits

We focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.

• CAR/TCR Development Kits
• Oncology

• CellRapeutics™ TCR Technology
• CAR × TCR Bispecific T Cells Engineering Platform
• CellRapeutics™ Chimeric Antigen Receptor (CAR) Technology
• Surfarray™ Cell Microarray Technology
• T-Scan Platform for High-throughput Identification of T Cell-specific Epitopes
• Animal Model Platform for CAR-T Therapy
• Gamma Delta (γδ) T Cell Platform
• Tetravalent Bispecific (TetraBi) T-cell Engager Platform
• CAR-T Cell Display Platform
• CAR-Stem Cell Platform
• CRISPR-edited CAR Cell Technology
• Stable Packaging Cell Line (PCL) Platform
• Immune Monitoring Platform
• mRNA-Based CAR Cell Platform
• Tseeking™ Platform For TCR/Ligand Discovery Solutions

To accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.

• CAR Technology
• TCR Technology

• Support Knowledge
• Downloads
• Newsletter
• Webinars
• Podcasts
• Publications

Use the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don't find the answers you're looking for, contact us for additional assistance.

• Flyers
• Newsletter